Using the <i>PEAR1</i> Polymorphisms Rs12041331 and Rs2768759 as Potential Predictive Markers of 90-Day Bleeding Events in the Context of Minor Strokes and Transient Ischemic Attack

In this study, we explored the relationship between the platelet endothelial aggregation receptor 1 (<i>PEAR1</i>) polymorphisms, platelet reactivity, and clinical outcomes in patients with minor stroke or transient ischemic attack (TIA). Randomized controlled trial subgroups were assess...

Full description

Bibliographic Details
Main Authors: Yanjie Xu, Dongxiao Yao, Weiqi Chen, Hongyi Yan, Dexiu Zhao, Lingling Jiang, Yicong Wang, Xingquan Zhao, Liping Liu, Yongjun Wang, Yuesong Pan, Yilong Wang
Format: Article
Language:English
Published: MDPI AG 2023-09-01
Series:Brain Sciences
Subjects:
Online Access:https://www.mdpi.com/2076-3425/13/10/1404
_version_ 1797574490200211456
author Yanjie Xu
Dongxiao Yao
Weiqi Chen
Hongyi Yan
Dexiu Zhao
Lingling Jiang
Yicong Wang
Xingquan Zhao
Liping Liu
Yongjun Wang
Yuesong Pan
Yilong Wang
author_facet Yanjie Xu
Dongxiao Yao
Weiqi Chen
Hongyi Yan
Dexiu Zhao
Lingling Jiang
Yicong Wang
Xingquan Zhao
Liping Liu
Yongjun Wang
Yuesong Pan
Yilong Wang
author_sort Yanjie Xu
collection DOAJ
description In this study, we explored the relationship between the platelet endothelial aggregation receptor 1 (<i>PEAR1</i>) polymorphisms, platelet reactivity, and clinical outcomes in patients with minor stroke or transient ischemic attack (TIA). Randomized controlled trial subgroups were assessed, wherein patients received dual antiplatelet therapy for at least 21 days. Platelet reactivity was measured at different time intervals. Genotypes were categorized as wild-type, mutant heterozygous, and mutant homozygous. Clinical outcomes were evaluated after 90 days. The rs12041331 polymorphism predominantly influenced adenosine diphosphate channel platelet activity, with the AA genotype displaying significantly lower residual platelet activity to the P2Y12 response unit (<i>p</i> < 0.01). This effect was more evident after 7 days of dual antiplatelet treatment (<i>p</i> = 0.016). Mutant A allele carriers had decreased rates of recurrent stroke and complex endpoint events but were more prone to bleeding (<i>p</i> = 0.015). The rs2768759 polymorphism majorly impacted arachidonic acid (AA) channel platelet activity, which was particularly noticeable in the C allele carriers. Our regression analysis demonstrated that rs12041331 AA + GA and rs2768759 CA predicted 90-day post-stroke bleeding. In conclusion, the <i>PEAR1</i> polymorphisms rs12041331 and rs2768759 interfere with platelet aggregation and the performance of antiplatelet drugs. These genetic variations may contribute to bleeding events associated with minor stroke and TIA.
first_indexed 2024-03-10T21:23:15Z
format Article
id doaj.art-201c634991fb410c90eb93ec4f6035e4
institution Directory Open Access Journal
issn 2076-3425
language English
last_indexed 2024-03-10T21:23:15Z
publishDate 2023-09-01
publisher MDPI AG
record_format Article
series Brain Sciences
spelling doaj.art-201c634991fb410c90eb93ec4f6035e42023-11-19T15:52:27ZengMDPI AGBrain Sciences2076-34252023-09-011310140410.3390/brainsci13101404Using the <i>PEAR1</i> Polymorphisms Rs12041331 and Rs2768759 as Potential Predictive Markers of 90-Day Bleeding Events in the Context of Minor Strokes and Transient Ischemic AttackYanjie Xu0Dongxiao Yao1Weiqi Chen2Hongyi Yan3Dexiu Zhao4Lingling Jiang5Yicong Wang6Xingquan Zhao7Liping Liu8Yongjun Wang9Yuesong Pan10Yilong Wang11Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing 100069, ChinaDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing 100069, ChinaDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing 100069, ChinaDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing 100069, ChinaDepartment of Neurology, Aviation General Hospital, Beijing 100025, ChinaDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing 100069, ChinaDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing 100069, ChinaDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing 100069, ChinaDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing 100069, ChinaDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing 100069, ChinaDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing 100069, ChinaDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing 100069, ChinaIn this study, we explored the relationship between the platelet endothelial aggregation receptor 1 (<i>PEAR1</i>) polymorphisms, platelet reactivity, and clinical outcomes in patients with minor stroke or transient ischemic attack (TIA). Randomized controlled trial subgroups were assessed, wherein patients received dual antiplatelet therapy for at least 21 days. Platelet reactivity was measured at different time intervals. Genotypes were categorized as wild-type, mutant heterozygous, and mutant homozygous. Clinical outcomes were evaluated after 90 days. The rs12041331 polymorphism predominantly influenced adenosine diphosphate channel platelet activity, with the AA genotype displaying significantly lower residual platelet activity to the P2Y12 response unit (<i>p</i> < 0.01). This effect was more evident after 7 days of dual antiplatelet treatment (<i>p</i> = 0.016). Mutant A allele carriers had decreased rates of recurrent stroke and complex endpoint events but were more prone to bleeding (<i>p</i> = 0.015). The rs2768759 polymorphism majorly impacted arachidonic acid (AA) channel platelet activity, which was particularly noticeable in the C allele carriers. Our regression analysis demonstrated that rs12041331 AA + GA and rs2768759 CA predicted 90-day post-stroke bleeding. In conclusion, the <i>PEAR1</i> polymorphisms rs12041331 and rs2768759 interfere with platelet aggregation and the performance of antiplatelet drugs. These genetic variations may contribute to bleeding events associated with minor stroke and TIA.https://www.mdpi.com/2076-3425/13/10/1404<i>PEAR1</i> geneplatelet aggregationdual antiplatelet therapystroketransient ischemic attackgenetic polymorphism
spellingShingle Yanjie Xu
Dongxiao Yao
Weiqi Chen
Hongyi Yan
Dexiu Zhao
Lingling Jiang
Yicong Wang
Xingquan Zhao
Liping Liu
Yongjun Wang
Yuesong Pan
Yilong Wang
Using the <i>PEAR1</i> Polymorphisms Rs12041331 and Rs2768759 as Potential Predictive Markers of 90-Day Bleeding Events in the Context of Minor Strokes and Transient Ischemic Attack
Brain Sciences
<i>PEAR1</i> gene
platelet aggregation
dual antiplatelet therapy
stroke
transient ischemic attack
genetic polymorphism
title Using the <i>PEAR1</i> Polymorphisms Rs12041331 and Rs2768759 as Potential Predictive Markers of 90-Day Bleeding Events in the Context of Minor Strokes and Transient Ischemic Attack
title_full Using the <i>PEAR1</i> Polymorphisms Rs12041331 and Rs2768759 as Potential Predictive Markers of 90-Day Bleeding Events in the Context of Minor Strokes and Transient Ischemic Attack
title_fullStr Using the <i>PEAR1</i> Polymorphisms Rs12041331 and Rs2768759 as Potential Predictive Markers of 90-Day Bleeding Events in the Context of Minor Strokes and Transient Ischemic Attack
title_full_unstemmed Using the <i>PEAR1</i> Polymorphisms Rs12041331 and Rs2768759 as Potential Predictive Markers of 90-Day Bleeding Events in the Context of Minor Strokes and Transient Ischemic Attack
title_short Using the <i>PEAR1</i> Polymorphisms Rs12041331 and Rs2768759 as Potential Predictive Markers of 90-Day Bleeding Events in the Context of Minor Strokes and Transient Ischemic Attack
title_sort using the i pear1 i polymorphisms rs12041331 and rs2768759 as potential predictive markers of 90 day bleeding events in the context of minor strokes and transient ischemic attack
topic <i>PEAR1</i> gene
platelet aggregation
dual antiplatelet therapy
stroke
transient ischemic attack
genetic polymorphism
url https://www.mdpi.com/2076-3425/13/10/1404
work_keys_str_mv AT yanjiexu usingtheipear1ipolymorphismsrs12041331andrs2768759aspotentialpredictivemarkersof90daybleedingeventsinthecontextofminorstrokesandtransientischemicattack
AT dongxiaoyao usingtheipear1ipolymorphismsrs12041331andrs2768759aspotentialpredictivemarkersof90daybleedingeventsinthecontextofminorstrokesandtransientischemicattack
AT weiqichen usingtheipear1ipolymorphismsrs12041331andrs2768759aspotentialpredictivemarkersof90daybleedingeventsinthecontextofminorstrokesandtransientischemicattack
AT hongyiyan usingtheipear1ipolymorphismsrs12041331andrs2768759aspotentialpredictivemarkersof90daybleedingeventsinthecontextofminorstrokesandtransientischemicattack
AT dexiuzhao usingtheipear1ipolymorphismsrs12041331andrs2768759aspotentialpredictivemarkersof90daybleedingeventsinthecontextofminorstrokesandtransientischemicattack
AT linglingjiang usingtheipear1ipolymorphismsrs12041331andrs2768759aspotentialpredictivemarkersof90daybleedingeventsinthecontextofminorstrokesandtransientischemicattack
AT yicongwang usingtheipear1ipolymorphismsrs12041331andrs2768759aspotentialpredictivemarkersof90daybleedingeventsinthecontextofminorstrokesandtransientischemicattack
AT xingquanzhao usingtheipear1ipolymorphismsrs12041331andrs2768759aspotentialpredictivemarkersof90daybleedingeventsinthecontextofminorstrokesandtransientischemicattack
AT lipingliu usingtheipear1ipolymorphismsrs12041331andrs2768759aspotentialpredictivemarkersof90daybleedingeventsinthecontextofminorstrokesandtransientischemicattack
AT yongjunwang usingtheipear1ipolymorphismsrs12041331andrs2768759aspotentialpredictivemarkersof90daybleedingeventsinthecontextofminorstrokesandtransientischemicattack
AT yuesongpan usingtheipear1ipolymorphismsrs12041331andrs2768759aspotentialpredictivemarkersof90daybleedingeventsinthecontextofminorstrokesandtransientischemicattack
AT yilongwang usingtheipear1ipolymorphismsrs12041331andrs2768759aspotentialpredictivemarkersof90daybleedingeventsinthecontextofminorstrokesandtransientischemicattack